AI/ML technologies are revolutionizing pharmaceutical formulation by optimizing excipient selection and predicting stability, reducing time and resources needed for development. Poor solubility of ...
In a new report, ‘Helping others: unlocking the potential of ‘other’ cancers through predictive analytics’, the Concr team – co-founders Matthew Foster and Matthew Griffiths, together with CEO Irina ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results